Campaign Against Drug Piracy Heats Up

Armen Hareyan's picture

Increased efforts and revamped strategy to fight counterfeiting and piracy in the U.S. pharmaceutical market and several other industries worldwide took place in June.

The Organization for Economic Cooperation and Development (OECD) released a report on June 4 about the economic impact of counterfeiting and piracy. The Coalition Against Counterfeiting and Piracy (CACP) announced a high-intensity campaign to strengthen enforcement of U.S. intellectual property rights laws.

CACP, led by the U.S. Chamber of Commerce, combines more than 200 disparate groups, ranging from the Pharmaceutical Research and Manufacturers of America (PhRMA) to the Motion Picture Association of America--all banded together to combat global piracy and counterfeiting.


Strength lies in unity, said Peter Pitts, a former Food and Drug Administration (FDA) associate commissioner and current president of the Center for Medicine in the Public Interest, a free-market group based in Washington, DC. If all CACP members work toward protecting intellectual property rather than fending for themselves, they can make a difference, Pitts said. A victory against pirated movies or music also helps prevent counterfeit drugs from entering the country, he said.

Six Goals

As part of that effort, said Katie Wilson, spokesperson for the U.S. Chamber of Commerce Global Anti-Counterfeiting and Piracy Initiative, CACP will focus on six goals: